FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elisabeth Bond

Research Profile

Genes & Molecular Sequences

Chemicals & Drugs

Disorders

Anatomy

Concepts & Ideas

Age of Onset

Physiology

Living Beings

Young Adult

Co-author Network

Publications

TOP 3
Karen S Yee; Helge Taubert; Peter Wurl; Elisabeth E Bond; Gareth Bond; Anna Grawenda; Lukasz Grochola; Garth Hamilton; Eric O'Neill
A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.
Alexei Vazquez; Lukasz F Grochola; Elisabeth E Bond; Arnold J Levine; Helge Taubert; Thomas H Müller; Peter Würl; Gareth Bond
Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival.
Gareth Bond; Kim M Hirshfield; Tomas Kirchhoff; Gabriella Alexe; Elisabeth E Bond; Harlan Robins; Frank Bartel; Helge Taubert; Peter Wuerl; William N Hait; Deborah Toppmeyer; Kenneth Offit; Arnold J Levine
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elisabeth Bond (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Karen S Yee; Helge Taubert; Peter Wurl; Elisabeth E Bond; Gareth Bond; Anna Grawenda; Lukasz Grochola; Garth Hamilton; Eric O'Neill
A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.
Cancer research 2012;72(9):2206-17.
2010: Alexei Vazquez; Lukasz F Grochola; Elisabeth E Bond; Arnold J Levine; Helge Taubert; Thomas H Müller; Peter Würl; Gareth Bond
Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival.
Cancer research 2010;70(1):172-80.
2006: Gareth Bond; Kim M Hirshfield; Tomas Kirchhoff; Gabriella Alexe; Elisabeth E Bond; Harlan Robins; Frank Bartel; Helge Taubert; Peter Wuerl; William N Hait; Deborah Toppmeyer; Kenneth Offit; Arnold J Levine
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner.
Cancer research 2006;66(10):5104-10.
2005: Sandra Harris; German Gil; Harlan Robins; Wenwei Hu; Kim M Hirshfield; Elisabeth E Bond; Gareth Bond; Arnold J Levine
Detection of functional single-nucleotide polymorphisms that affect apoptosis.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(45):16297-302.
2005: Sandra Harris; G Gil; W Hu; H Robins; Elisabeth E Bond; Kim M Hirshfield; Z Feng; X Yu; A K Teresky; Gareth Bond; Arnold J Levine
Single-nucleotide polymorphisms in the p53 pathway.
Cold Spring Harbor symposia on quantitative biology 2005;70():111-9.
2004: Gareth Bond; Wenwei Hu; Elisabeth E Bond; Harlan Robins; Stuart G Lutzker; Nicoleta C Arva; Jill Bargonetti; Frank Bartel; Helge Taubert; Peter Wuerl; Kenan Onel; Linwah Yip; Shih-Jen Hwang; Louise C Strong; Guillermina Lozano; Arnold J Levine
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.
Cell 2004;119(5):591-602.